May 11, 2022 / 07:00PM GMT
Travis Lee Steed - BofA Securities, Research Division - MD
Welcome to the BofA Healthcare Conference. Up next, we have Becton, Dickinson. I'm Travis Steed, the medical device analyst here at BofA, and we're welcome to have Chris DelOrefice, Chief Financial Officer; and Simon Campion, President of the Interventional segment. So great. Welcome. And Chris, I think you wanted to start off with some opening comments, kind of just a few takeaway, some -- the recent quarter that you had last week.
Christopher DelOrefice - Becton, Dickinson and Company - Executive VP & CFO
Yes. Absolutely. So first thing, thanks for having us. Thanks, everyone, for joining. Good to see everyone in person.
Yes, as I reflect on the quarter, I think a couple of things. One -- I think 2 key things maybe to highlight. One, I think what you're really seeing play out in both our second fiscal quarter and our first quarter results is really our BD 2025 strategy coming to life, really strong growth. As you saw, as a matter of fact, year-to-date, we're just about 9% growth. And I
Becton Dickinson and Co at Bank of America Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers